Core Laboratories Inc
(CLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 25,262 | 10,738 | 69 | 32,153 | 24,684 |
| Depreciation Amortization | 10,981 | 7,387 | 3,717 | 14,953 | 11,289 |
| Income taxes - deferred | -4,573 | -3,167 | -1,817 | 674 | 102 |
| Accounts receivable | -615 | -3,717 | -5,938 | -3,612 | -9,461 |
| Accounts payable and accrued liabilities | 1,284 | 6,647 | 2,971 | 519 | -373 |
| Other Working Capital | -5,394 | -504 | -1,841 | 7,879 | -2,828 |
| Other Operating Activity | 2,140 | 3,199 | 9,499 | 3,822 | 12,360 |
| Operating Cash Flow | $29,085 | $20,583 | $6,660 | $56,388 | $35,773 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,589 | -5,711 | -2,349 | -11,292 | -7,713 |
| Net Acquisitions | -617 | -617 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -2 | N/A | N/A | 20 | N/A |
| Other Investing Activity | 10,727 | 5,456 | 3,121 | 4,898 | 4,878 |
| Investing Cash Flow | $1,521 | $-872 | $772 | $-6,394 | $-2,835 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 36,000 | 25,000 | 13,000 | 44,000 | 38,000 |
| Debt Repayment | -47,000 | -27,000 | -15,000 | -82,000 | -62,000 |
| Common Stock Repurchased | -9,770 | -4,761 | -2,022 | -5,306 | -402 |
| Dividend Paid | -1,403 | -938 | -469 | -1,876 | -1,407 |
| Other Financing Activity | -1,961 | 19 | 9 | -775 | -775 |
| Financing Cash Flow | $-24,134 | $-7,680 | $-4,482 | $-45,957 | $-26,584 |
| Beginning Cash Position | 19,157 | 19,157 | 19,157 | 15,120 | 15,120 |
| End Cash Position | 25,629 | 31,188 | 22,107 | 19,157 | 21,474 |
| Net Cash Flow | $6,472 | $12,031 | $2,950 | $4,037 | $6,354 |
| Free Cash Flow | |||||
| Operating Cash Flow | 29,085 | 20,583 | 6,660 | 56,388 | 35,773 |
| Capital Expenditure | -10,937 | -7,907 | -3,579 | -13,028 | -8,647 |
| Free Cash Flow | 18,148 | 12,676 | 3,081 | 43,360 | 27,126 |